Surgery for Obesity and Related Diseases最新文献

{"title":"A prospective study on the effect of reoperations on abdominal pain after bariatric surgery: the OPERATE study","authors":"Daniko P. Sindhunata M.D. ,&nbsp;Marjolein R.A. Vink M.D. ,&nbsp;Barbara A. Hutten Ph.D. ,&nbsp;Nienke van Olst M.D., Ph.D. ,&nbsp;Yair I.Z. Acherman M.D. ,&nbsp;Gabi Fritsche ,&nbsp;Dilara Yugnuk ,&nbsp;Max Nieuwdorp M.D., Ph.D. ,&nbsp;Arnold W. van de Laar M.D., Ph.D. ,&nbsp;Victor E.A. Gerdes M.D., Ph.D.","doi":"10.1016/j.soard.2024.10.021","DOIUrl":"10.1016/j.soard.2024.10.021","url":null,"abstract":"<div><h3>Background</h3><div>Abdominal pain after bariatric surgery (BS) is not uncommon. A number of patients require reoperation. Limited studies have investigated the outcome of reoperations for abdominal pain after BS.</div></div><div><h3>Objectives</h3><div>To assess abdominal pain and quality of life after reoperation in patients with abdominal pain after BS.</div></div><div><h3>Setting</h3><div>Bariatric center in the Netherlands.</div></div><div><h3>Methods</h3><div>The study involved patients with a reoperation for abdominal pain after BS. Patients completed questionnaires on abdominal complaints and quality of life after inclusion, 3 months, and 6 months after reoperation. Clinical data were collected from records. Patients were compared on the basis of preoperative provisional diagnoses and postoperative diagnoses.</div></div><div><h3>Results</h3><div>A total of 179 patients were included, with laparoscopic Roux-en-Y gastric bypass (86.0%), at a median of 27 months [9.5–76.0] after BS. Six months after reoperation, 51.6% continued to experience pain. However, a decline in pain severity was observed (visual analog scale baseline 83.50 [75.0–95.0] and 6 months 0 [.0–44.0] (<em>P</em> &lt; .001). Patients without postoperative diagnosis had more pain after 6 months (<em>P</em> = .048). Gastrointestinal Quality of Life Index improved over time for all patients (94–110) (<em>P</em> &lt; .001); however, no significant improvement was observed in patients without a preoperative provisional diagnosis. The general indication of health decreased for all patients (<em>P</em> &lt; .001).</div></div><div><h3>Conclusions</h3><div>Abdominal pain intensity decreased during follow-up upon reoperation after BS; however, in approximately one half of the patients, the pain remained and a decline in general health indication was observed regardless of postoperative diagnosis. These findings underscore the need for comprehensive management strategies to address post-BS pain and well-being.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 3","pages":"Pages 216-227"},"PeriodicalIF":3.5,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nissen sleeve gastrectomy: 5-year follow-up results","authors":"Natalia Savvala M.D. ,&nbsp;Mailis Amico Ph.D. ,&nbsp;Saaddedine Joumaa M.D. ,&nbsp;Audrey Jaussent ,&nbsp;Marta Silvestri M.D. ,&nbsp;Patrick Lefebvre M.D. ,&nbsp;Arvin Khamajeet M.D. ,&nbsp;Marie Christine Picot M.D. ,&nbsp;Florence Galtier M.D. ,&nbsp;David Nocca M.D., Ph.D.","doi":"10.1016/j.soard.2024.10.019","DOIUrl":"10.1016/j.soard.2024.10.019","url":null,"abstract":"<div><h3>Background</h3><div>Nissen sleeve gastrectomy is a new bariatric procedure based on the combination of 2 well-known surgical techniques (vertical sleeve gastrectomy and Nissen fundoplication). It was conceived as a means to prevent the major drawback of the sleeve gastrectomy (SG), the gastroesophageal reflux disease (GERD), while preserving the advantages of SG in terms of weight loss, and remission of obesity-related comorbidities.</div></div><div><h3>Objectives</h3><div>The objectives of this study are to present the long-term (5 years) follow-up results on weight loss, evolution of GERD and other comorbidities, and the complication rate of the Nissen sleeve gastrectomy.</div></div><div><h3>Setting</h3><div>Montpellier University Hospital, France.</div></div><div><h3>Methods</h3><div>This is a prospective analysis of patients who underwent Nissen sleeve gastrectomy as a first-line bariatric procedure between January 2018 and February 2019. A subgroup analysis of patients with no further surgery during follow-up was also performed.</div></div><div><h3>Results</h3><div>A total of 144 patients underwent Nissen sleeve gastrectomy: After adjusting for exclusion criteria, 133 patients comprised the initial study population, 81.9% of whom had complete follow-up for weight and GERD clinical symptom outcomes at 5 years. The mean total weight loss (TWL%) was 22 (±12.3)% and the mean excess weight loss percentage (EWL%) was 59.4% (±34.2)%. Of the 63 patients with preoperative clinical symptoms of GERD, we observed an 85.5% 5-year clinical remission rate; however, only 25 patients had a gastroscopy at 5 years. The cumulative short- and long-term reoperation rate was 8.1% and the mortality rate was zero.</div></div><div><h3>Conclusions</h3><div>The Nissen sleeve gastrectomy achieves a satisfactory long-term TWL% and a significant improvement in comorbidities, particularly regarding the incidence of GERD. The rate of complications requiring surgical reoperation is low.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 3","pages":"Pages 311-318"},"PeriodicalIF":3.5,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142756076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of sleeve gastrectomy on populations with obesity and obstructive sleep apnea: a meta-analysis","authors":"Peng Cao M.D. ,&nbsp;Jiake Li M.D. ,&nbsp;Guohui Wang M.D. ,&nbsp;Xulong Sun M.D. ,&nbsp;Zhi Luo M.D. ,&nbsp;Shaihong Zhu M.D. ,&nbsp;Liyong Zhu M.D.","doi":"10.1016/j.soard.2024.10.007","DOIUrl":"10.1016/j.soard.2024.10.007","url":null,"abstract":"<div><h3>Background</h3><div>Obstructive sleep apnea (OSA) is highly prevalent in patients with morbid obesity, prompting interest in bariatric surgery as a potential management strategy. Sleeve gastrectomy (SG), being the primary bariatric surgical option, offers simplicity, reduced postoperative complications, and favorable outcomes for obesity and its associated conditions.</div></div><div><h3>Objectives</h3><div>This study aims to assess the efficacy of SG in treating populations with obesity and OSA.</div></div><div><h3>Setting</h3><div>University-affiliated hospital, China.</div></div><div><h3>Methods</h3><div>We conducted a comprehensive literature search across PubMed, Embase, Cochrane Library, and Web of Science databases to identify pertinent studies published up to March 28, 2024. Our review encompassed studies that assessed the effectiveness of SG on primary outcomes, including the apnea-hypopnea index (AHI), as well as secondary outcomes such as forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), nonrapid eye movement sleep stage 3 (NREM 3), rapid eye movement sleep (REM), sleep efficiency (SE), arousal index, Epworth sleepiness scale (ESS), oxygen desaturation index (ODI), apnea index (AI), meanSpO2, body mass index (BMI), weight, neck circumference (NC), waist circumference (WC), waist-to-hip ratio (WHR), subcutaneous fat area (SFA), visceral fat area (VFA), systolic blood pressure(SBP)/diastolic blood pressure(DBP), and measurements related to glucolipid metabolism. A total of 12 eligible studies underwent a systematic screening process and were subsequently subjected to meta-analysis using either randomized effects model or fixed-effect models.</div></div><div><h3>Results</h3><div>Significant reductions in AHI, BMI, weight, SFA, and VFA were observed following SG. Correspondingly, enhancements in FVC, meanSpO2, NREM 3%, REM%, and SE, were noted after SG. Additionally, the populations with obesity and OSA exhibited decreases in arousal index, ODI, AI, ESS, NC, WC, WHR, and DBP post-SG. Moreover, reductions in HOMA-IR and glycosylated hemoglobin were also observed after SG.</div></div><div><h3>Conclusion</h3><div>SG demonstrates favorable outcomes in the populations with obesity and OSA.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 3","pages":"Pages 288-300"},"PeriodicalIF":3.5,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142635492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cartoon","authors":"","doi":"10.1016/j.soard.2024.10.002","DOIUrl":"10.1016/j.soard.2024.10.002","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 11","pages":"Page 1182"},"PeriodicalIF":3.5,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142437937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SOARD Category 1 CME Credit Featured Articles, Volume 20, November 2024","authors":"","doi":"10.1016/j.soard.2024.10.001","DOIUrl":"10.1016/j.soard.2024.10.001","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 11","pages":"Pages 1179-1181"},"PeriodicalIF":3.5,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142437936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of food tolerance among bariatric surgery procedures: a systematic review","authors":"Marieh Salavatizadeh M.Sc. ,&nbsp;Mohammad Reza Amini Ph.D. ,&nbsp;Fereshteh Abbaslou M.D. ,&nbsp;Alireza Amirbeigi M.D.","doi":"10.1016/j.soard.2024.10.009","DOIUrl":"10.1016/j.soard.2024.10.009","url":null,"abstract":"<div><div>Bariatric surgeries are related to reduced food tolerance (FT), which may impact on nutritional status and weight loss treatment. The present study was conducted to compare the effects of gastric banding (GB), sleeve gastrectomy (SG), and Roux-en-<span>Y</span> gastric bypass (RYGB) on FT. A literature search was performed using Scopus, PubMed, Web of Science, and Google Scholar to find relevant studies published up to August 2023. The primary outcome was the postoperative overall FT score assessed by the Quality of Alimentation questionnaire. Overall, 27 studies containing 4366 adults were included in the review: 15 cohort studies, 5 interventional studies, and 7 cross-sectional studies. The quality of articles ranged between low and high. Thirteen studies evaluated the effect of SG on FT; however, 4 studies reported FT following RYGB. The postsurgery FT of GB patients was examined in 1 study. The mixture of bariatric techniques was evaluated in 9 papers. Selected studies assessed FT from 1 month to 5 years following obesity surgery. Taken together, GB patients showed the lowest level of FT. Although SG and RYGB patients had no difference in FT, RYGB ones had better tolerance to protein-rich foods such as red meat, white meat, and fish. Both SG and RYGB individuals tolerated vegetables and fish more than other food groups and could least tolerate red meat and grains. After the first postoperative year, a good level of FT was found among SG and RYGB patients.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 3","pages":"Pages 319-328"},"PeriodicalIF":3.5,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development of venous thromboembolic event risk calculator for metabolic and bariatric surgery patients to reduce mortality","authors":"Maher El Chaar M.D. ,&nbsp;Luis Alvarado M.S. ,&nbsp;Abdelrahman Nimeri M.D. ,&nbsp;Tanujit Dey Ph.D. ,&nbsp;Benjamin Clapp M.D. ,&nbsp;Ann M. Rogers M.D. ,&nbsp;Anthony T. Petrick M.D.","doi":"10.1016/j.soard.2024.09.007","DOIUrl":"10.1016/j.soard.2024.09.007","url":null,"abstract":"<div><h3>Background</h3><div>Venous Thromboembolic events (VTE) after Metabolic and Bariatric Surgery (MBS) result in significant morbidity and are the leading cause of mortality.</div></div><div><h3>Objective</h3><div>The objective of this study was to identify patients who are at a high risk for developing VTE and who may benefit from extended chemoprophylaxis following MBS.</div></div><div><h3>Setting</h3><div>Multi-institutional study.</div></div><div><h3>Methods</h3><div>Using the 2015-2019 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) participant user file (PUF), we identified 696,069 patients who completed 30-day follow-up data and met the inclusion criteria. Using logistic regression analysis, we identified preoperative and postoperative risk factors associated with VTE and validated our model externally using the MBSAQIP 2020-2021 datasets (N = 273,692). The Hosmer–Lemeshow test was used for goodness of fit and calibration. We also compared our model’s discriminatory capability with that of other VTE risk assessment tools. We then used these risk factors to create an online open source application.</div></div><div><h3>Results</h3><div>The overall incidence of VTE after MBS in the 696,069 (MBSAQIP 2015-2019 database) patients included in our analysis was .40% (2759 patients). Our model had a good predictive capability, with a C-statistic of .66. Our model also demonstrated good fit with a Hosmer–Lemeshow chi-square of 11.06 (<em>P</em> = .198). A cut-off point of .4% resulted in a sensitivity of 48.28%, with 24% of patients having a VTE risk greater than .4% within the 2015-2019 MBSAQIP dataset. Among all the perioperative factors selected in the PUF, high risk for VTE included African American race (adjusted odds ratios [AOR] 1.625, <em>P</em> &lt; .0001), operation length in minutes (AOR: 1.003, <em>P</em> &lt; .0001), preop functional status (AOR 1.012, <em>P</em> = .007), procedure type (Roux en Y Gastric Bypass; AOR .768, <em>P</em> &lt; .0001 and RBS; AOR .758, <em>P</em> = .019 with respect to sleeve), preop body mass index (BMI) (AOR 1.012, <em>P</em> &lt; .001), history of pre-op vein thrombosis requiring therapy (AOR 5.041, <em>P</em> &lt; .0001), post-op superficial or organ space surgical site infection (AOR 2.713, <em>P</em> &lt; .0001), preop venous stasis (AOR 1.425, <em>P</em> = .019),at least one readmission within 30 days(AOR 1.583, <em>P</em> &lt; .0001), or at least one reoperation within 30 days (AOR 4.399, <em>P</em> &lt; .0001).</div></div><div><h3>Conclusion</h3><div>VTE after MBS can result in increased mortality rates. High-risk patients might benefit from extended chemoprophylaxis. Our model suggests that patients with a VTE risk ≥ .4% in the first 30 days following surgery may benefit from extended chemoprophylaxis.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 3","pages":"Pages 228-239"},"PeriodicalIF":3.5,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142756075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study","authors":"Xiaodong Shan M.D. ,&nbsp;Yongjin Wang M.B. ,&nbsp;Xiaoao Xiao M.B. ,&nbsp;Yuanqing Gao Ph.D. ,&nbsp;Xitai Sun M.D.","doi":"10.1016/j.soard.2024.09.013","DOIUrl":"10.1016/j.soard.2024.09.013","url":null,"abstract":"<div><h3>Background</h3><div>Whether preoperative exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with postoperative nausea and vomiting (PONV) after laparoscopic sleeve gastrectomy (LSG) remains unclear.</div></div><div><h3>Objectives</h3><div>To investigate the association between preoperative GLP-1RAs exposure and PONV after LSG.</div></div><div><h3>Setting</h3><div>University Hospital, China.</div></div><div><h3>Methods</h3><div>We reviewed a retrospective cohort of patients underwent LSG between January 1, 2017, and December 30, 2021 at Nanjing Drum Tower Hospital, dividing the patients into 2 groups on the basis of whether they were exposed to GLP-1RAs preoperatively. A 1:1 propensity score matching was performed to balance the characteristics between the groups. Associations between GLP-1RAs exposure and PONV were determined by logistic regressions.</div></div><div><h3>Results</h3><div>A total of 564 eligible patients underwent LSG, 351 (62.2%, 95% CI 58.2–66.1) of whom had PONV. In total cohort, PONV occurred in 72(84.7%) patients exposed to GLP-1RAs preoperatively and 279 (58.2%) patients not exposed to GLP-1RAs (adjusted odds ratio 6.782, 95% confidence interval 3.307–13.907, <em>P</em> &lt; .001). In the 158 matched patients, PONV occurred in 66 (83.5%) patients exposed to GLP-1RAs preoperatively and 48 (60.8%) matched patients not exposed to GLP-1RAs (adjusted odds ratio 3.830, 95% confidence interval 1.461–10.036, <em>P</em> = .006). Subgroup analysis by dosage forms and doses revealed a positive association between greater doses and an increased risk of PONV after LSG for both once-daily and once-weekly formulations.</div></div><div><h3>Conclusions</h3><div>Preoperative exposure to GLP-1RAs is associated with an increased risk of PONV in patients undergoing LSG, particularly at higher doses of exposure.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 3","pages":"Pages 247-255"},"PeriodicalIF":3.5,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Remission of hypertension after laparoscopic sleeve gastrectomy versus Roux-en-Y-gastric bypass: a systematic review of randomized control trials","authors":"Alba Zevallos M.D. ,&nbsp;Elijah E. Sanches M.D. ,&nbsp;Chetan Parmar M.D. ,&nbsp;Rui Ribeiro M.D. ,&nbsp;Sjaak Pouwels M.D., Ph.D.","doi":"10.1016/j.soard.2024.10.010","DOIUrl":"10.1016/j.soard.2024.10.010","url":null,"abstract":"<div><h3>Background</h3><div>Besides its benefits for weight loss, current findings suggest that bariatric surgery can induce remission of hypertension. Limited data report the effect of bariatric surgery on this obesity-associated comorbidity.</div></div><div><h3>Objective</h3><div>Compare the short-term, mid-term, and long-term remission of hypertension after sleeve gastrectomy versus Roux-en-Y gastric bypass.</div></div><div><h3>Setting</h3><div>Meta-analysis of randomized controlled trials (RCTs).</div></div><div><h3>Methods</h3><div>Four databases (Embase, PubMed, Scopus, and Science Direct) were searched for RCTs that compared the effects of sleeve gastrectomy (SG) versus Roux-en-Y gastric bypass (RYGB) on hypertension remission at &lt;1 year, 2–4 years, and ≥5 years. Patients with a history of hypertension and who had primary bariatric surgery were included.</div></div><div><h3>Results</h3><div>After reviewing 11,814 studies, only 11 RCTs were included. In total, the analysis included 2323 patients, with 1158 in the SG group (49.85%) and 1165 in the RYGB group (50.15%). It was found that SG and RYGB procedures had comparable hypertension remission at ≤1 year (Relative risk: 1.11, 95% CI .83–1.48, <em>P</em> = .49), and between 2 and 4 years (Relative risk: 1.11, 95% CI .90–1.37, <em>P</em> = .34). However, there was a significant difference in hypertension remission at ≥ 5 years, favoring RYGB (relative risk: 1.39, 95% CI 1.06–1.82, <em>P</em> = .02).</div></div><div><h3>Conclusion</h3><div>This systematic review and meta-analysis of RCTs demonstrates that RYGB is superior to SG in resolving hypertension beyond 5 years postoperatively. These findings highlight the long-term benefits of RYGB over SG in managing hypertension, providing valuable insights for surgical decision-making and patient counseling.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 3","pages":"Pages 271-278"},"PeriodicalIF":3.5,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A high adherence level to nutritional recommendations minimizes protein and minerals loss while maximizes visceral fat loss in bariatric surgery patients","authors":"Hadil Subih Ph.D. ,&nbsp;Shirin Batayneh M.A. ,&nbsp;Belal Obeidat Ph.D. ,&nbsp;Mohammad Rashdan M.D. ,&nbsp;Firas Obeidat M.D. ,&nbsp;Jareer Heider Abuhmeidan M.D. ,&nbsp;Shannon Galyean Ph.D. ,&nbsp;Leen B. Obeidat M.D. ,&nbsp;Zouheyr Hadri Ph.D. ,&nbsp;Linda Alyahya Ph.D.","doi":"10.1016/j.soard.2024.10.011","DOIUrl":"10.1016/j.soard.2024.10.011","url":null,"abstract":"<div><h3>Background</h3><div>Metabolic bariatric surgeries are considered the finest and most appropriate treatment option for patients with severe obesity. Besides the surgical procedure, many factors appear to be associated with improved postoperative outcomes such as compliance to the postoperative diet and supplementation, regular physical activity, medical and nutritional follow-up, and modifications in dietary habits.</div></div><div><h3>Objectives</h3><div>The objectives of this study were to investigate the effect of adherence to postoperative recommendations on anthropometric measurements and body composition and assess the percentage of total weight loss (%TWL) and excess weight loss (%EWL) 3 months postoperative.</div></div><div><h3>Settings</h3><div>Fifty-two participants who underwent a Roux-en-Y gastric bypass or sleeve gastrectomy in the University of Jordan Hospital were included.</div></div><div><h3>Methods</h3><div>Participants have filled out a preoperative questionnaire. Anthropometric measurements were obtained preoperative and 3 months postoperative using a Body Impedance Analyzer (Inbody 270). The adherence to postoperative recommendations was assessed by the Bariatric Surgery Self-management Questionnaire 3 months postoperative and classified to 3 adherence levels.</div></div><div><h3>Results</h3><div>Most anthropometric measurements decreased 3 months postoperative in the 3 adherence groups (<em>P</em> ≤ .05). No significant differences were observed between groups in anthropometric measurements and body composition, except for minerals and visceral fat levels. The mineral loss has decreased in both the high and intermediate adherence groups (−.09 ± .22 kg, and −.09 ± .18 kg, respectively). Also, the high adherence group showed less loss in protein amount postoperatively (<em>P</em> = .06). Visceral fat level decreased in the high adherence group (<em>P</em> ≤ .05).</div></div><div><h3>Conclusions</h3><div>Adherence to postoperative behavioral and nutritional recommendations was associated with less protein and mineral loss and enhanced visceral fat reduction postoperatively.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 3","pages":"Pages 301-310"},"PeriodicalIF":3.5,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142873639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}